The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The phase II study of pembrolizumab plus lenvatinib for patients with unresectable cutaneous angiosarcoma (Pembro-Lenva for cAS/PLAS trial).
 
Dai Ogata
Research Funding - MSD
 
Eiji Nakano
No Relationships to Disclose
 
Takeru Funakoshi
Honoraria - Maruho
Speakers' Bureau - Bristol-Myers Squibb Japan; Kyowa Kirin International; Maruho; MSD; Novartis; Ono Pharmaceutical
Research Funding - Ono Pharmaceutical
 
Akira Takahashi
Speakers' Bureau - Pharmaceutical Industries, Inc, Bristol-Myers Squibb, and Novartis Pharma, Inc.
 
Jun Asai
Speakers' Bureau - MSD; Ono Yakuhin
 
Motoki Nakamura
Speakers' Bureau - Merck KGaA; Ono Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Mandom
 
Kenjiro Namikawa
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - MSD; Novartis
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Ono Pharmaceutical (Inst)
 
Ryunosuke Machida
No Relationships to Disclose
 
Masayuki Yokoyama
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; m3.com
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); ONO PHARMACEUTICAL (Inst)
 
Yukari Nagasaka
No Relationships to Disclose
 
Kazumi Kurishita
No Relationships to Disclose
 
Yoshie Shuda
No Relationships to Disclose
 
Kenta Anjo
Employment - Abbvie (I)
 
Kanako Kondo
No Relationships to Disclose
 
Masako Inaba
No Relationships to Disclose
 
Satoshi Kawashima
No Relationships to Disclose
 
Takako Hitomi
No Relationships to Disclose
 
Natsuko Okita
No Relationships to Disclose
 
Naoya Yamazaki
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Chugai Pharma; Eisai; Merck; Ono Pharmaceutical; Otsuka
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Novartis; Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb Japan (Inst); HUYA Bioscience International (Inst); MSD (Inst); Novartis (Inst); Regeneron (Inst); Takara Bio (Inst)